Categories: News

Sanofi: Information concerning the total number of voting rights and shares – September 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi
a French société anonyme with a registered share capital of 2,534,952,234 €
Registered office : 54, rue La Boétie – 75008 Paris – France
Registered at the Paris Commercial and Companies Registry under number 395 030 844

Date  

Total number of
issued shares

 

Number of real
voting rights
(excluding treasury shares)
Theoretical number of
voting rights
(including treasury shares)*
September 30, 2022 1,267,479,766 1,411,899,228 1,425,326,874

* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.

This information is also available on the internet website of sanofi under « Regulated Information in France »:
https://www.sanofi.com/en/investors/sanofi-share-and-adrs/share-overview/shares-and-voting-rights/

Investor Relations Department
e-mail: investor.relations@sanofi.com

 

 

Attachment

Staff

Recent Posts

TKSoftware Inc. Unveils ICONIC Pro: The All-In-One Medical Billing & Clearinghouse Solution

TKSoftware Inc. today launches ICONIC Pro, a unified, cloud–based platform that combines claims submission, electronic…

3 hours ago

Monarch Athletic Club: A Longevity Clinic Disguised as an Athletic Club

LOS ANGELES, June 23, 2025 /PRNewswire/ -- Monarch Athletic Club, the Los Angeles-based wellness disruptor…

3 hours ago

ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer

Most Recently Serving as President for Oticon, a Division of Demant, Rosenblum Brings 30+ Years…

6 hours ago

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI), a company working to improve outcomes for…

9 hours ago

As Dangerous US Heat Wave Intensifies, AccuWeather Urges Public to Rely on Science-Backed RealFeel® Temperature for Accurate Danger Index

AccuWeather's RealFeel® Temperature is the only authentic formula-based metric—unlike 'Feels Like,' which lacks scientific credibility.Request…

9 hours ago